Gram-positiveCocciCatalase-negative

Streptococcus pneumoniae

Encapsulated, alpha-hemolytic, Gram-positive lancet-shaped diplococcus and the leading cause of community-acquired pneumonia, bacterial meningitis, and otitis media.

Organism Card

DomainMust know
Identity
  • Gram-positive lancet-shaped diplococci [1][2]
  • α-haemolytic streptococcus
  • Polysaccharide capsule (major virulence factor; >90 serotypes)
  • Human-only nasopharyngeal commensal/carrier
Lab discriminator
  • α-haemolysis on blood agar (green zone) — like viridans strep
  • Optochin sensitive (vs viridans strep = optochin resistant)
  • Bile soluble (vs viridans strep = bile insoluble)
  • Quellung reaction (capsular swelling with type-specific antisera)
  • Urine pneumococcal antigen test — rapid, unaffected by prior Abx [3][4]
Reservoir / transmission
  • Nasopharyngeal colonisation in healthy individuals (esp. children)
  • Droplet / autoinoculation from colonised URT
  • Risk groups: extremes of age, asplenic / hyposplenic, immunocompromised, chronic lung disease, post-influenza [5][6][7]
Key virulence
  • Polysaccharide capsule → anti-phagocytic; requires opsonisation by Ab + complement for clearance
  • IgA protease → mucosal immune evasion
  • Pneumolysin → cytotoxin, activates complement, damages respiratory epithelium
  • Autolysin → cell wall release → triggers intense inflammation
Clinical syndromes
  • Most common cause of CAP (~24%) — rusty sputum, lobar consolidation [1][8]
  • Bacterial meningitis in adults — onset may be explosive, mortality ~20% [9]
  • Otitis media & sinusitis (commonest bacterial cause in children) [10]
  • Bacteraemia / sepsis (esp. asplenic → OPSI, >50% due to S. pneumoniae) [5][6]
  • Spontaneous bacterial peritonitis (Gram +ve cause in cirrhotic ascites) [11]
  • Pneumococcal HUS in children (pneumonia + empyema/effusion) [12]
  • Necrotizing pneumonia (less common than S. aureus) [12]
Diagnosis
  • Sputum Gram stain + C/ST (lancet-shaped G+ve diplococci)
  • Blood culture ×2 (esp. severe CAP)
  • Urine S. pneumoniae antigen test — rapid, high specificity [3][4]
  • CSF: ↑PMN, ↑protein, ↓glucose ( < 50% serum), Gram stain sens 60–90% [9]
  • Pitfall: prior Abx → culture-negative; urine Ag still detectable
Treatment
  • In ALL cases of CAP, cover S. pneumoniae [1][4]
  • CAP empirical (HA guideline): Augmentin ± macrolide/doxycycline [3][4]
  • Meningitis: 3G cephalosporin (cefotaxime / ceftriaxone) + vancomycin empirically; 10–14 d [9]
  • IV dexamethasone for pneumococcal meningitis — ↓mortality & ↓hearing loss; give before/with 1st Abx dose [9]
  • IE: IV penicillin G ± gentamicin [13]
  • Resistance caveat: penicillin-intermediate/resistant strains emerging; high-dose penicillin or 3G cephalosporin for non-meningeal; vancomycin added for meningeal
Prevention
  • PCV13 (13-valent conjugate vaccine) — in HK Childhood Immunisation Programme [10][12]
  • PPSV23 for adults ≥65 y, chronic disease, immunocompromised
  • Pre-splenectomy vaccination (Pneumococcus + Hib + Meningococcus + Influenza) ≥2 wk before elective; ASAP if emergency [5][6]
  • Post-splenectomy: early Abx (Augmentin) for febrile episodes; some advocate lifelong penicillin V (not routine in HK) [5][6]
  • Notifiable disease: invasive pneumococcal disease
Classic traps
  • Optochin-sensitive + bile-soluble = pneumococcus (vs viridans strep: optochin-R, bile-insoluble)
  • Post-influenza pneumonia → think S. pneumoniae or S. aureus [8]
  • Asplenic patient + fulminant sepsis = S. pneumoniae until proven otherwise [5][6]
  • Complement deficiency (C3, C5–C9) → encapsulated bacteria including pneumococcus [14]
  • Serotype 3 can cause pneumonia + empyema even in vaccinated children (PCV13 covers it but vaccine effectiveness lower for serotype 3) [15]
  • Do NOT confuse with S. pyogenes (β-haemolytic, bacitracin-sensitive)

Exam Intelligence

On this page

No Headings